Astek Diagnostics Inc.
Elkridge, MD
- UEI
- DWMKQ81LJLW1
- CAGE
- 8QMK0
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 6413 Woodland Forest Dr, Elkridge, MD 21075, USA
- Website
- astekdx.com
- Founded
- 2020
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Cobio Diagnostics Inc. | Aurora, CO | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Bioamp Diagnostics Inc. | San Carlos, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Scanogen Inc. | Milford Mill, MD | 339113 Surgical Appliance and Supplies Manufacturing |
| Nanopath Inc. | Cambridge, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Pattern Bioscience, Inc. | Austin, TX | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Astek Diagnostics Inc. is a minority-owned, for-profit corporate entity registered in SAM.gov that specializes in developing advanced medical diagnostic technologies, with a primary focus on rapid antibiotic susceptibility testing (AST) platforms. The company is dedicated to revolutionizing clinical diagnostics by creating innovative solutions that can quickly identify bacterial infections and determine appropriate antibiotic treatments. Located in Halethorpe, Maryland, Astek Diagnostics has been actively pursuing technological innovations in medical diagnostics, primarily through Small Business Innovation Research (SBIR) grant programs.
The company has secured multiple federal grants from the National Science Foundation (NSF), specifically targeting the development of rapid detection methods for bacterial infections and antibiotic resistance. Their primary research has centered on creating an AST platform capable of delivering results within one hour for various specimen types, including urine, cerebrospinal fluid, and wound effluent. The grants, ranging from $255,975 to $991,832, have supported their work in developing optical technologies and microfluidic assays to assess bacterial metabolism and antibiotic susceptibility. These projects aim to address critical healthcare challenges, such as reducing morbidity and mortality from infections like urinary tract infections, urosepsis, meningitis, and wound infections, while also combating the growing threat of antimicrobial resistance. The NSF's Technology, Innovation, and Partnerships (TIP) and Division of Industrial Innovation programs have been instrumental in supporting Astek Diagnostics' innovative research and development efforts.
Quick answers
Is Astek Diagnostics Inc. registered in SAM.gov?
Yes. Astek Diagnostics Inc.'s SAM.gov registration is active through August 15, 2027.
What is Astek Diagnostics Inc.'s CAGE code?
Astek Diagnostics Inc.'s CAGE code is 8QMK0, and its Unique Entity ID (UEI) is DWMKQ81LJLW1.
What is Astek Diagnostics Inc.'s most recent federal award?
Astek Diagnostics Inc.'s most recent federal grant award is Sbir phase II: automated one-hour testing for bacterial detection and antibiotic sensitivity in clinical samples (2423587), from National Science Foundation, on September 15, 2024.
On GovTribe
See Astek Diagnostics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors